Lipids

Peter H. Jones, MD, discussed identifying high-risk patients and targeting specific lipid therapy to reduce risk of future cardiovascular disease events.

In part 5 of our series on lipid management, Paul Jellinger, MD, MACE, highlights the importance of coronary artery calcium score as a risk factor for ASCVD and its role in diagnosis and treatment of...

He discusses his latest research on how managing lipid levels with the Wahls diet and other integrative interventions affects fatigue related to multiple sclerosis.

Michael Bloch, MD, talks about latest clinical data for PCSK9 inhibitors in lowering LDL-C and cardiovascular events, current evidence for the optimum LDL-C goals for patients with hypercholesterolemia, and...

James Matera, MD, talks about the association between cardiometabolic diseases and hyperkalemia, the benefits and risks of various treatment approaches for chronic hyperkalemia, and more.

In this podcast, Laurence Sperling, MD, from Emory University School of Medicine, explains the newest ACC/AHA cholesterol guidelines, the top 10 take-home messages for cardiologists, and the lessons learned...

In part 4 of our series on lipid management, Paul Jellinger, MD, explains the answer to the quiz question from part 3 of the series and talks about the role of the MESA Study in the treatment of ASCVD. ...